Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 1
2009 1
2012 1
2015 1
2017 1
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance.
Stagakis I, Bertsias G, Karvounaris S, Kavousanaki M, Virla D, Raptopoulou A, Kardassis D, Boumpas DT, Sidiropoulos PI. Stagakis I, et al. Among authors: karvounaris s. Arthritis Res Ther. 2012 Jun 12;14(3):R141. doi: 10.1186/ar3874. Arthritis Res Ther. 2012. PMID: 22691241 Free PMC article. Clinical Trial.
Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study.
Karvounaris SA, Sidiropoulos PI, Papadakis JA, Spanakis EK, Bertsias GK, Kritikos HD, Ganotakis ES, Boumpas DT. Karvounaris SA, et al. Ann Rheum Dis. 2007 Jan;66(1):28-33. doi: 10.1136/ard.2006.053488. Epub 2006 Jun 22. Ann Rheum Dis. 2007. PMID: 16793841 Free PMC article.